Charles River Laboratories CRL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$142.16M— | —— | $480.37M-2.5% | $492.61M+23.5% | ||
| $403.31M+11.5% | $361.74M+15.2% | $314.12M+3.4% | $303.87M+14.4% | ||
| $71.08M+1.7% | $69.89M-3.0% | $72.05M-2.1% | $73.62M+3.0% | ||
| —— | -$67.43M-32.5% | -$50.9M-41.9% | -$35.88M-49.5% | ||
| $165M-23.3% | $215M— | $0— | —— | ||
| —— | —— | -$995K-101% | $123.41M+393% | ||
| $6.06M-59.0% | $14.77M-18.9% | $18.23M+172% | $6.71M+305% | ||
| -$35.74M-65.4% | -$21.61M— | —— | —— | ||
| —— | -$16.8M-127% | $62.3M-20.7% | $78.52M— | ||
| —— | —— | —— | —— | ||
| $81.87M— | —— | —— | —— | ||
| —— | —— | -$38.64M— | —— | ||
| -$38.14M— | —— | -$21.74M-138% | $57.66M+530% | ||
| $737.65M+0.4% | $734.58M+7.4% | $683.9M+10.4% | $619.64M-18.6% | ||
| $219.15M-5.9% | $232.97M-26.9% | $318.53M-1.9% | $324.73M+41.9% | ||
| $0— | —— | —— | —— | ||
| $20.08M-62.0% | $52.88M-2.5% | $54.22M-65.7% | $158.27M+247% | ||
| —— | $0— | $0-100% | $163.28M+33.1% | ||
| -$209.32M+14.6% | -$245.09M+56.5% | -$563.16M+13.7% | -$652.31M+54.9% | ||
| $360.67M+203% | $119.18M+393% | $24.16M-37.5% | $38.65M-5.1% | ||
| $1.23B+13.5% | $1.08B+39.3% | $776.35M-73.7% | $2.95B-57.5% | ||
| $1.35B-9.7% | $1.49B+75.4% | $851.68M-71.0% | $2.93B-53.0% | ||
| $714K-97.0% | $23.88M-6.7% | $25.6M+1.9% | $25.11M-45.0% | ||
| -$536.73M+2.6% | -$550.93M— | —— | -$42.4M— | ||
| —— | —— | $8.21M-68.0% | $25.61M+44.4% | ||
| $10.43M— | —— | $43.27M— | —— | ||
| —— | —— | -$995K-101% | $123.41M+393% | ||
| $259.08M+400% | $51.83M+23.6% | $41.92M— | —— | ||
| —— | —— | —— | $30.46M+80.0% | ||
| $81.87M— | —— | —— | —— | ||
| $12.81M-66.7% | $38.47M+512% | $6.29M+5.3% | $5.97M— | ||
| —— | -$33.25M— | —— | —— | ||
| $6.06M-59.0% | $14.77M-18.9% | $18.23M+172% | $6.71M+305% | ||
| —— | —— | $97.83M— | —— | ||
| -$3.36M+26.0% | -$4.55M-298% | $2.29M-75.5% | $9.35M— | ||
| -$14.02M+55.4% | -$31.44M-659% | -$4.15M— | —— | ||
| $1.35B-9.7% | $1.49B+75.4% | $851.68M-71.0% | $2.93B-53.0% | ||
| $518.49M+3.4% | $501.61M+37.3% | $365.37M+23.9% | $294.91M-44.6% | ||
| $518.49M+3.4% | $501.61M+37.3% | $365.37M+23.9% | $294.91M-44.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $607.0M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $215.7M of capital expenditures, Charles River Laboratories's free cash flow was $391.3M over the trailing twelve months, down 30.5% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
